TP53 and medulloblastoma: PDOX models of very-high-risk SHH medulloblastoma (MYCN amplified, TP53 mutation) and G3 medulloblastoma (MYC amplified) [18] labeled with firefly luciferase were generated in mice, which were monitored for tumor burden by bioluminescence imaging (BLI).